PBM Psyence Biomedical Ltd. Common Shares

USD 0.86 0.00 0
Icon

Psyence Biomedical Ltd. Common Shares (PBM) Stock Analysis and Price Targets

| Others | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.8589

0.00 (0.00)%

N/A

0.08M

N/A

N/A

Icon

PBM

Psyence Biomedical Ltd. Common Shares (USD)
| NSD
USD 0.86
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 0.86

Psyence Biomedical Ltd. Common Shares (PBM) Stock Forecast

N/A

Based on the Psyence Biomedical Ltd. Common Shares stock forecast from 0 analysts, the average analyst target price for Psyence Biomedical Ltd. Common Shares is not available over the next 12 months. Psyence Biomedical Ltd. Common Shares’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Psyence Biomedical Ltd. Common Shares is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Psyence Biomedical Ltd. Common Shares’s stock price was USD 0.8589. Psyence Biomedical Ltd. Common Shares’s stock price has changed by +26.57% over the past week, -27.21% over the past month and 0% over the last year.

No recent analyst target price found for Psyence Biomedical Ltd. Common Shares
No recent average analyst rating found for Psyence Biomedical Ltd. Common Shares

Company Overview Psyence Biomedical Ltd. Common Shares

N/A

N/A

N/A

N/A

USD

United States

Adjusted Closing Price for Psyence Biomedical Ltd. Common Shares (PBM)

Loading...

Unadjusted Closing Price for Psyence Biomedical Ltd. Common Shares (PBM)

Loading...

Share Trading Volume for Psyence Biomedical Ltd. Common Shares Shares

Loading...

Compare Performance of Psyence Biomedical Ltd. Common Shares Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PBM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Psyence Biomedical Ltd. Common Shares (Sector: Others )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
QQQM
Invesco NASDAQ 100 ETF 0.00 (0.00%) USD22.00B N/A N/A

ETFs Containing PBM

Symbol Name PBM's Weight Expense Ratio Price(Change) Market Cap
TPMN
Timothy Plan Market Neutr.. 23.73 % 0.65 % 0.00 (0.00%) USD0.04B

Frequently Asked Questions About Psyence Biomedical Ltd. Common Shares (PBM) Stock

Stock Target Advisor's fundamental analysis for Psyence Biomedical Ltd. Common Shares's stock is Neutral.

Unfortunately we do not have enough data on PBM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PBM's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PBM's stock to indicate if its overvalued.

The last closing price of PBM's stock was USD 0.86.

Unfortunately we do not currently have any market capitalization data for PBM's stock.

Unfortunately we do not have enough analyst data on PBM's stock to indicate whether its price will go up or not.

Following are ETFs with the highest allocation to Psyence Biomedical Ltd. Common Shares's stock :

TPMN

Sorry, we do not have any data on the number of employees for Psyence Biomedical Ltd. Common Shares.

Sorry we do not have any infomation available on Psyence Biomedical Ltd. Common Shares's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...